Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1)

Abraxane (Abr), a US Food and Drug Administration-approved albumin-bound nanoparticle applied for the treatment of non-small-cell lung cancer, has been reported to be more effective than paclitaxel (PTX). To further understand the molecular mechanisms that produce this superior drug efficacy of Abr,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Nanomedicine
Huvudupphovsmän: Zhao, Minzhi, Li, Haiyun, Ma, Yan, Gong, He, Yang, Shu, Fang, Qiaojun, Hu, Zhiyuan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2017
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5338994/
https://ncbi.nlm.nih.gov/pubmed/28280335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S129976
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk